Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Anxiety DisorderDepressionFatigueLung Cancer
Interventions
DRUG

cisplatin

80 mg/m2 administered by intravenous (IV) over 30 minutes on Day 1 following the gemcitabine infusion. Treatment repeated every 21 days for a total of 6 cycles.

DRUG

fluoxetine

10 mg PO QD (by mouth once daily) starting on week 2 (day 8) and continuing for 7 weeks (days 8-57). After 7 weeks of fluoxetine treatment (day 57), further use of fluoxetine is at the discretion of the patient and physician.

DRUG

gemcitabine hydrochloride

1000 mg/m2 intravenous (IV) administered by IV over 30 minutes on days 1 and 8. Repeat treatment every 21 days for a total of 6 cycles.

Trial Locations (43)

10021

Memorial Sloan-Kettering Cancer Center, New York

11373

Elmhurst Hospital Center, Elmhurst

11432

Queens Cancer Center of Queens Hospital, Jamaica

13210

State University of New York - Upstate Medical University, Syracuse

Veterans Affairs Medical Center - Syracuse, Syracuse

13217

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse

20422

Veterans Affairs Medical Center - Washington, DC, Washington D.C.

21201

Veterans Affairs Medical Center - Baltimore, Baltimore

22901

Martha Jefferson Hospital, Charlottesville

23502

Virginia Oncology Associates - Norfolk, Norfolk

24014

Oncology and Hematology Associates of Southwest Virginia, Inc., Roanoke

25701

St. Mary's Medical Center, Huntington

27705

Veterans Affairs Medical Center - Durham, Durham

28025

NorthEast Oncology Associates, Concord

28374

FirstHealth Moore Regional Hospital, Pinehurst

28805

Veterans Affairs Medical Center - Asheville, Asheville

32804

Florida Hospital Cancer Institute, Orlando

33021

Memorial Regional Hospital Comprehensive Cancer Center, Hollywood

33316

Broward General Medical Center, Fort Lauderdale

33401

Helen and Harry Gray Cancer Institute at Good Samaritan Medical Center, West Palm Beach

36207

Northeast Alabama Regional Medical Center, Anniston

40207

Baptist Hospital East - Louisville, Louisville

49085

Lakeland Medical Center - St. Joseph, Saint Joseph

54501

Ministry Medical Group - Northern Region, Rhinelander

58102

Veterans Affairs Medical Center - Fargo, Fargo

60305

West Suburban Center for Cancer Care, River Forest

60640

Louis A. Weiss Memorial Hospital, Chicago

61108

Saint Anthony Medical Center, Rockford

63110

Barnes-Jewish Hospital, St Louis

65203

Ellis Fischel Cancer Center - Columbia, Columbia

75216

Veterans Affairs Medical Center - Dallas, Dallas

89106

Veterans Affairs Medical Center - Las Vegas, Las Vegas

92161

Veterans Affairs Medical Center - San Diego, San Diego

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Beth Israel Medical Center, Boston

68198-7680

University of Nebraska Medical Center, Omaha

08103

Cooper University Hospital, Camden

28302-2000

Cape Fear Valley Health System, Fayetteville

28503-1678

Lenoir Memorial Hospital Cancer Center, Kinston

28402-9025

New Hanover Regional Medical Center, Wilmington

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00005850 - Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter